Drug details:
Molecular formula: C₃₂H₅₀N₄O₆

Standard name: (3S,6R,9R,12S,16R)-12-benzyl-6-methyl-3,9-bis(2-methylpropyl)-16-pentyl-1-oxa-4,7,10,13-tetrazacyclohexadecane-2,5,8,11,14-pentone

Curated SMILES: CCCCC[C@@H]1CC(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)O1)CC(C)C)C)CC(C)C)CC2=CC=CC=C2

Evidence for compound's anti-virulence activity:

Staphylococcus
Related VF: δ-hemolysin
Target: Not determined
Drug effect: An agr quorum sensing inhibitor impedes δ-toxin production .
Max phase: Preclinical (in vivo)
Publication:
Baldry M, et al., 2018. Application of an agr-Specific Antivirulence Compound as Therapy for Staphylococcus aureus-Induced Inflammatory Skin Disease. J Infect Dis 218(6):1009-1013.